bad-blood
The best thing about "Bad Blood" is its gripping narrative and the in-depth investigation into the rise and fall of Theranos, which keeps readers engaged and informed. Reviewers praise the author's ability to weave complex details into a compelling story. On the other hand, some readers noted that the book could occasionally feel overwhelming with its extensive array of characters and technical details, making it challenging to follow for those less familiar with the subject matter.
Key Insights
- The “fake it till you make it” ethos taken to criminal extreme. Theranos and Elizabeth Holmes operated on a Silicon Valley cultural logic — project certainty, suppress doubt, move fast — that works for software startups where failure is recoverable. Applied to medical diagnostics where patients make life-and-death decisions based on results, the same logic became fraud. The culture wasn’t anomalous; it was the same culture, different stakes.
- Secrecy and NDA culture as fraud’s enabler. Theranos maintained near-total information asymmetry through aggressive NDAs, legal threats, and compartmentalization. Employees who raised concerns were fired or threatened; board members with relevant technical expertise (like George Shultz’s grandson) were dismissed. The secrecy that Silicon Valley treats as competitive protection became the mechanism of concealment.
- The board as a failure of governance. Theranos’s board was stacked with distinguished political and military figures — Shultz, Mattis, Kissinger — who had no relevant technical expertise and who deferred completely to Holmes. The prestige of the board created legitimacy without providing oversight. This is a structural problem that extends beyond Theranos.
- Holmes’s mimicry of Steve Jobs as a tell, not a feature. The black turtleneck, the reality distortion field, the vision talk — Holmes consciously modeled herself on Jobs. Carreyrou’s reporting suggests this mimicry was partly strategic and partly delusional. The Silicon Valley mythology of the visionary founder who ignores naysayers provides cover for fraud because it makes skepticism look like small-mindedness.
- Journalism as the last line of defense. Theranos survived regulatory gaps, deferential investors, and a legal system that moves slowly. It was broken by Carreyrou’s investigative reporting at the WSJ. The book is partly an argument about what investigative journalism is for — and what happens when it doesn’t exist.
— Drafted from external sources; review and edit to make your own.